Clinical trial
Toremifene in Treating Patients With Desmoid Tumors
NCT00002595 · Advocate Lutheran General Hospital, Other · Completed
Key facts
| NCT number | NCT00002595 |
|---|---|
| Title | Toremifene in Treating Patients With Desmoid Tumors |
| Official title | PHASE II STUDY OF THE SAFETY AND EFFICACY OF TOREMIFENE IN THE THERAPY OF DESMOID TUMORS |
| Lead sponsor | Advocate Lutheran General Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Desmoid Tumor |
| Intervention type | Drug, Procedure |
| Interventions | toremifene, conventional surgery |
| Enrollment | 72 |
| Start date | Jul 1, 1991 |
| Primary completion | May 1, 2003 |
| Completion | Sep 1, 2010 |
| First posted | Apr 22, 2004 |
| Last update posted | Jul 10, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: